Dr. Shapiro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-744-5100
Summary
- I am a board-certified infectious diseases specialist and internal medicine physician. I have a primary care HIV clinic and attend on inpatient general medicine and infectious diseases consult services.
Education & Training
- University of WashingtonFellowship, Infectious Disease, 2015 - 2019
- University of California (San Francisco)Residency, Internal Medicine, 2013 - 2015
- Johns Hopkins University School of MedicineClass of 2013
Certifications & Licensure
- CA State Medical License 2014 - Present
- WA State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 178 citationsEffect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya
JAMA. 2022-04-05 - 651 citationsEarly Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya
The New England Journal of Medicine. 2021-10-27 - 97 citationsEpidemiology of helminth infections and their relationship to clinical malaria in southwest UgandaAdrienne E Shapiro, Edridah M. Tukahebwa, Jennifer Kasten, Siân E. Clarke, Pascal Magnussen
Transactions of the Royal Society of Tropical Medicine and Hygiene. 2005-01-01
Press Mentions
- Among People with HIV, Mpox Vaccine Protects WellOctober 10th, 2024
- What You Need to Know About COVID-19 VaccinesOctober 29th, 2021
- Monoclonal Antibody Treatment Highly Effective at Reducing COVID-19 HospitalizationsOctober 28th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: